Twin Health, a company focused on metabolic health solutions, today announced it has secured $53,000,000 in new investment capital. This funding round underscores investor confidence in the company’s innovative approach to chronic disease management and its potential for market expansion.
Twin Health integrates advanced medical science and technology with a clinical care team to help individuals gain control over conditions like type 2 diabetes, prediabetes, and obesity. The company's unique Digital Twin™ technology learns a member’s specific metabolism by analyzing data from smart devices, meal logs, and lab work. This allows for real-time, personalized recommendations on nutrition, activity, sleep, and stress, with a dedicated clinical team providing ongoing guidance and support. Twin Health's metabolic health benefit is made available exclusively through employers or health plans.
The company has demonstrated significant clinical and financial outcomes, reporting that 73% of members have eliminated medications, including injections, and an average weight loss of 14 pounds in six months. Additionally, Twin Health reports generating substantial annual savings for its partners, with projected pharmacy savings of $3.2 million annualized across members with high-cost medications. These results contribute to the significance of the current funding, which is intended to accelerate the company’s strategic growth.
This newly raised capital will be deployed to support Twin Health's continued expansion, enabling the company to scale its operations and enhance its Digital Twin™ technology and clinical programs. The investment is expected to bolster Twin Health's capacity to reach a broader population, furthering its mission to improve metabolic health outcomes. The company looks forward to leveraging this funding to deepen its impact on the healthcare market and empower more individuals to achieve lasting health improvements.
